BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 10, 2022-- CANbridge Pharmaceuticals Inc. (HKEX:1228) , a China and US-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, announced that […]
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress
– Data from 75 patients with transfusion-dependent beta thalassemia or severe sickle cell disease with follow-up of up to 37.2 months continue to demonstrate that exa-cel has the potential to be a one-time functional cure – – Safety profile generally consistent with myeloablative conditioning and […]
Collegium Pharmaceutical: Oversold And Cheap
Collegium Pharmaceutical: Oversold And Cheap [Collegium Pharmaceutical, Inc. (COLL)] Summary - Shares of pain management drug concern Collegium Pharmaceutical have fallen over 40% as the biotech selloff, negative attitudes towards opiates, and patent cliffs have taken a toll. - The company's recent […]
Cell Cycle Analysis Market to Reach US$ Million at xx% CAGR During the Forecast Period 2017 – 2025
TMRR recently published a market study on the global Cell Cycle Analysis market that sheds light on the various trends that are playing an imperative role in shaping the growth of the Cell Cycle Analysis market. The report provides a detailed analysis of the Cell Cycle Analysis supply chain, value […]
Five Beaten-Up Biotech Stocks Saw Big Share Purchases
Text size Biotech stocks have taken some lumps this year, and some have seen some large stock purchases made by big shareholders. Shares of cancer-therapy developers Kymera Therapeutics (ticker: KYMR), Cullinan Oncology (CGEM), and Repare Therapeutics (RPTX) are down 77%, 22%, and 35%, respectively, […]
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress
– Data from 75 patients with transfusion-dependent beta thalassemia or severe sickle cell disease with follow-up of up to 37.2 months continue to demonstrate that exa-cel has the potential to be a one-time functional cure – – Safety profile generally consistent with myeloablative conditioning and […]
Webinar – How Allegiance Health Management Increased Revenue and Addressed Patients’ Ability to Pay
Patient debt is at an all-time high as provider margins increasingly become razor thin. Addressing this problem is therefore a top priority for health providers and health system decision-makers. An upcoming webinar on Thursday, June 23rd, 2022, will examine how Allegiance Health Management reshaped […]
Eli Lilly Gets FDA Approval for First Autoimmune Alopecia Drug
The US Food and Drug Administration (FDA) has approved Eli Lilly’s drug Olumiant for alopecia areata (AA), an autoimmune disorder that causes significant hair loss. The approval is a major win for Lilly, which was racing against Pfizer and Concert Pharmaceuticals to bring the first therapeutic to […]
FDA Decisions on China-based Trials Speeds Transition to Multiregional Clinical Trials
The US Food and Drug Administration (FDA) has taken an increasingly tough stance on clinical trials performed primarily in China in recent years, with the agency rejecting two drugs for that reason just last month. A recent article by Richard Pazdur, director of the Oncology Center of Excellence at […]
Medical Affairs Strategic Leadership Forum | November 8-9, 2022 | Philadelphia, PA – Hybrid Event
The upcoming Medical Affairs Strategic Leadership Forum will bring together global medical affairs leaders to help plot the course of the medical affairs industry. Developing new engagement models with healthcare providers (HCPs) will require novel insights driven by real-world evidence (RWE). At […]
Study Finds Drug Launch Prices Grew 20% Annually Since 2008
A new study published in JAMA found that launch prices for new drugs have steadily climbed since 2008, with the average ballooning from $2,115 to over $180,000. The researchers examined the cost of 548 drugs using launch price data from the SSR Health drug price database. A representative from the […]
Pharmaceutical industry less affected in pandemic – Economy – Vietnam News | Politics, Business, Economy, Society, Life, Sports – VietNam News
A worker operates equipment at a Traphaco plant. In the first quarter of 2022, after-tax profit of Traphaco Joint Stock Company (TRA) grew by 60.2 per cent. —Photo traphaco.com.vn HÀ NỘI While most manufacturing and trading industries faced difficulties due to rising input prices, the pharmaceutical […]
Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock and Pre-funded Warrants
CAMBRIDGE, Mass. and BOULDER, Colo. , June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of an underwritten public offering of 15,169,698 shares of […]
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
When Cynthia Johnson learned she would owe $200 out-of-pocket for a diagnostic mammogram in Houston, she almost put off getting the test that told her she had breast cancer. “I thought, ‘I really don’t have this to spend, and it’s probably nothing,’” said Johnson, who works in educational assessment […]
Cogent Biosciences Announces Pricing of Upsized Public
CAMBRIDGE, Mass. and BOULDER, Colo., June 13, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of an underwritten public offering of 15,169,698 shares of […]
FDA’s treatment of China-developed drugs spurs demands for multiregional clinical trials
China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical trials, leading to the FDA rejecting […]
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
Michelle Andrews When Cynthia Johnson learned she would owe $200 out-of-pocket for a diagnostic mammogram in Houston, she almost put off getting the test that told her she had breast cancer. “I thought, ‘I really don’t have this to spend, and it’s probably nothing,’” said Johnson, who works in […]
A Blueprint To Advance Patient-Centered Core Impact Sets
A Blueprint To Advance Patient-Centered Core Impact Sets Editor’s Note This article is part of a Health Affairs Forefront short series, “Enhancing Value By Evaluating Health Care Services.” The series discusses ways to extend the use of tools for clinical and economic evaluation beyond medical […]
Global Biosimilars Market Trends, Application and Regional Forecast to 2022-2028
Global Biosimilars Market Trends, Application and Regional Forecast to 2022-2028 [Bharat Book] [sonikashukla98] . Bharat Book Bureau Provides the Trending Market Research Report on “Global Biosimilars Market 2022-2028”under Life Sciences Market Research Report Category. The report offers a […]
Global Biosimilars Market Analysis, Application & Forecast to 2022-2028
Bharat Book Bureau Provides the Trending Market Research Report on “Global Biosimilars Market 2022-2028” under Life Sciences Market Research Report Category. The report offers a collection of superior Market research, Market analysis, competitive intelligence and Market reports. Biosimilars are […]
Demand for Cleanroom Consumables to Scale New Heights as Market Players Focus on Innovations 2017 – 2025
The report on the global Cleanroom Consumables market published by TMRR provides a clear understanding of the flight of the Cleanroom Consumables market over the forecast period (2019-2029). The study introspects the various factors that are tipped to influence the growth of the Cleanroom […]
Todos Medical Reports Day 45 Update for Case Study #6
New York, NY, and Tel Aviv, ISRAEL Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned subsidiary 3CL Pharma, Ltd. reported a Day 45 update from an ongoing case study by Dr. Lee Morgentaler of a 3CL protease […]
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress – Market Newsdesk
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress –Data from 75 patients with transfusion-dependent beta thalassemia or severe sickle cell disease with […]
OmniComm Systems (OTCMKTS:OMCM) & Olo (NYSE:OLO) Head-To-Head Review
OmniComm Systems ( OTCMKTS:OMCM – Get Rating ) and OLO ( NYSE:OLO – Get Rating ) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst […]
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress
Vertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) Congress – Data from 75 patients with transfusion-dependent beta thalassemia or severe sickle cell disease with […]
Copay, Reimbursement and Access Congress | October 12-14, 2022 | Philadelphia, PA – Hybrid Event
This October 12th-14th, professionals from the managed care and healthcare industries will convene in Philadelphia PA at the 2022 Copay, Reimbursement and Access Congress. Attendees will have opportunities to learn from and connect with peers and industry leaders. The conference will also be held […]
Roche’s Vabysmo Could Nab Nearly One Third of Regeneron’s Eylea Patients
Roche’s intraocular injectable Vabysmo has made impressive gains since its approval in January, cranking up the heat on Regeneron’s Eylea. Vabysmo treats wet-age macular degeneration (AMD) and diabetic macular edema (DME), preserving vision for up to four months per treatment. This stands in […]
Whitepaper: Mastering CX for Specialty Care in the Digital Age
The customer experience (CX) is an essential piece of quality specialty care. However, achieving excellent CX requires a carefully planned approach. In a newly available whitepaper, data and insights from nearly 400 specialty care pharma leaders are distilled into actionable items to advance […]
FDA Vocalizes Support for Moderna and Pfizer Vaccines for Children Under 5 One Day Before Advisory Committee
The US Food and Drug Administration (FDA) has signalled support for authorizing the Moderna and Pfizer COVID-19 vaccines for children under the age of 5 just one day before the agency’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is set to meet. The recommended authorization […]
FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis
|Real-time Euronext Paris - 06/07 11:38:01 am EDT| |99.99||EUR||-0.17%| |05:05p| |04:58p| |04:46p| Children treated with Dupixent and topical corticosteroids (TCS) achieved clearer skin, experienced significantly improved overall disease severity and significantly reduced itch compared to TCS alone […]
